Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Daily briefing: First drug shown to reduce deaths among people seriously ill with COVID-19
A cheap and widely available steroid called dexamethasone “will clearly have a massive global impact” as a coronavirus drug. Plus, the super-eruption that once rocked Yellowstone.
Almost nine million years ago, the Yellowstone volcanic hotspot, which stretches over areas of the western United States, experienced one of the largest eruptions ever known. An array of analyses has revealed that rocks once thought to have formed in several distinct eruptions came from a single ‘super-eruption’. The event scattered 2,800 cubic kilometres of rock and ash over an area of tens of thousands of square kilometres. “When you get your maps out and measure the scale, you think, ‘That can’t be right,’” says geochemist Thomas Knott. “‘They can’t possibly be that far apart and be from the same volcanic eruption.’”
Researchers aiming to quantify global happiness on social media have called the period starting on 26 May “the saddest two weeks” on Twitter. Since 2008, a pair of applied mathematicians have been gauging the positivity and negativity of randomly sampled tweets. Their happiness index had been gradually recovering from the bleak beginnings of the coronavirus pandemic, but dropped sharply following the killing of George Floyd in Minnesota late last month. The lowest point, in May, was far below the previous record, hit after a mass shooting in Las Vegas, Nevada, in 2017. But sadness can galvanize people into action. “It’s one thing to tell the world ‘this is the saddest week’,” says social scientist Desmond Patton. “But also in the saddest week, you have thousands and thousands of people who are now activated and moving towards equality and social justice.”
The head of the US National Oceanic and Atmospheric Administration (NOAA) violated the agency’s ethics code last year when he backed up US President Donald Trump’s claims that a hurricane could hit Alabama, finds a NOAA panel. The panel concluded that acting administrator Neil Jacobs “engaged in the misconduct intentionally, knowingly, or in reckless disregard” of the agency’s scientific-integrity policy by censoring its office in Birmingham, Alabama, which had tweeted that the state would not see a major impact from Hurricane Dorian. The controversy was dubbed ‘sharpiegate’ after Trump showed a NOAA map that had been altered with a black marker during a press conference last September.
A cheap and widely available steroid called dexamethasone is the first drug to be shown to reduce deaths among people seriously ill with COVID-19. Researchers working with the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial, which is assessing the capacity of six medications to treat the disease, announced the findings in a press release. The results have not yet been peer reviewed.
The study enrolled 2,100 participants who received dexamethasone and tracked how they fared in comparison with about 4,300 people who received standard care. For people on ventilators, it reduced deaths by about one-third. For patients needing oxygen, it cut the risk of death by one-fifth. The drug seems to reduce the damage from a hyperactive immune reaction called cytokine storm.
One of the most crucial questions about an emerging infectious disease such as the new coronavirus is how deadly it is — the infection fatality rate (IFR). This is the proportion of infected people who will die as a result, including those who don’t get tested or show symptoms. Now, numerous studies — using a range of methods — estimate that 0.5-1% of people infected with SARS-CoV-2 will die. There are many caveats: the IFR is particularly hard to pin down for COVID-19 because there are many infected people who don’t show symptoms, and many countries are struggling to count all their virus-related deaths.
A ranking of the world’s health-care systems, drawn up before the pandemic by iconoclastic health researcher Ezekiel Emanuel, “presciently marks the United States among the worst in class”, writes reviewer Eric Topol. Emanuel dug deep into 22 dimensions on topics including health-insurance coverage, financing, payment, delivery, pharmacy prices and workforce. Nowhere is crowned outright winner, but four strong contenders — Germany, the Netherlands, Norway and Taiwan — have so far been among the most successful in managing COVID-19.
A questionable data set from a mysterious company has forced high-profile retractions and thrown doubt on drug trials and public-health policies. The Nature news team explores the fallout for research and for public trust.
Are your turtles tired, your spiders jaded or your fish oddly bold? Ten years to the day after the call to widen the pool of human participants in psychology studies beyond those from WEIRD societies (that’s Western, Educated, Industrialized, Rich and Democratic), animal-behaviour researchers Michael Webster and Christian Rutz write that “mounting evidence suggests that there could be similar sampling problems in research on animals”. They propose a framework with a fitting acronym — STRANGE — that researchers can use to design studies, and to declare and discuss potential biases.
Intensive-care physician Kenneth Baillie, who serves on the steering committee of the RECOVERY coronavirus-drug trial, responds to results suggesting that dexamethasone reduces deaths among seriously ill people with COVID-19. (Nature | 5 min read)